Literature DB >> 12720073

Antidepressant prescribing in community cancer care.

Fredrick D Ashbury1, Lisa Madlensky, Peter Raich, Mark Thompson, Geoff Whitney, Ken Hotz, Boris Kralj, William S Edell.   

Abstract

GOALS: To describe patterns of antidepressant (ADs) prescribing in community oncology practice. PATIENTS AND METHODS: Data were collected using an electronic medical record on all staged breast, colon, and lung cancer patients in three community-based oncology practices. The data were analyzed retrospectively, using descriptive and bivariate analyses and multivariate logistic regression modeling. There were 850 breast, 299 colon, and 473 lung cancer patients identified in this analysis. MAIN
RESULTS: Overall, 19.2% of breast, 11% of colon, and 13.7% of lung cancer patients had been prescribed ADs during the 2-year period. The clinic in which cancer treatment was received predicted AD prescribing. The relationship between AD administration and age proved to be nonlinear; the pattern exhibited an "inverted U" shape. Patients with comorbidities and on pain medications were more likely to be administered ADs. Colon cancer patients on pain medications were five times more likely to be administered ADs than those not on pain medications.
CONCLUSIONS: While some predictors of AD prescribing appear to be consistent with other studies, such as being on pain medication, there is still a great amount of variability in prescribing patterns across community practices, age groups, and cancer diagnoses. This study demonstrates that prescriptions of ADs seem to be influenced by parameters other than psychopathology. Given the importance of major depression in oncology care, diagnosis of psychiatric disorders and prescription patterns of psychotropics should be part of the routine monitoring and quality management in oncology patient care.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12720073     DOI: 10.1007/s00520-003-0446-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  25 in total

1.  Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management.

Authors:  R M Berard; F Boermeester; G Viljoen
Journal:  Psychooncology       Date:  1998 Mar-Apr       Impact factor: 3.894

2.  Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period.

Authors:  F C Stiefel; A B Kornblith; J C Holland
Journal:  Cancer       Date:  1990-02-15       Impact factor: 6.860

3.  Prevalence of mood disorders and utility of the PRIME-MD in patients undergoing radiation therapy.

Authors:  K A Leopold; T A Ahles; S Walch; R J Amdur; L A Mott; L Wiegand-Packard; T E Oxman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-12-01       Impact factor: 7.038

4.  Psychotropic medications and the oncology patient.

Authors:  R Pies
Journal:  Cancer Pract       Date:  1996 May-Jun

Review 5.  Diagnosis and treatment of depression in cancer patients.

Authors:  W F Pirl; A J Roth
Journal:  Oncology (Williston Park)       Date:  1999-09       Impact factor: 2.990

Review 6.  Depression in palliative care: a pragmatic report from the Expert Working Group of the European Association for Palliative Care.

Authors:  F Stiefel; M Die Trill; A Berney; J M Olarte; A Razavi
Journal:  Support Care Cancer       Date:  2001-10       Impact factor: 3.603

7.  Influence of psychological response on survival in breast cancer: a population-based cohort study.

Authors:  M Watson; J S Haviland; S Greer; J Davidson; J M Bliss
Journal:  Lancet       Date:  1999-10-16       Impact factor: 79.321

8.  Coping and survival in lung cancer: a 10-year follow-up.

Authors:  Hermann Faller; Heinrich Bülzebruck
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

9.  The recognition of psychiatric morbidity on a medical oncology ward.

Authors:  A Hardman; P Maguire; D Crowther
Journal:  J Psychosom Res       Date:  1989       Impact factor: 3.006

10.  Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool.

Authors:  W Dugan; M V McDonald; S D Passik; B D Rosenfeld; D Theobald; S Edgerton
Journal:  Psychooncology       Date:  1998 Nov-Dec       Impact factor: 3.894

View more
  30 in total

Review 1.  Antidepressant use in ambulatory cancer patients.

Authors:  H Florence Kim; Michael J Fisch
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

2.  Use of and spending on supportive care medications among Medicare beneficiaries with cancer.

Authors:  Ilene H Zuckerman; Amy J Davidoff; Mujde Z Erten; Bruce Stuart; Thomas Shaffer; J Samantha Dougherty; Candice Yong
Journal:  Support Care Cancer       Date:  2014-08       Impact factor: 3.603

3.  Severe functional limitation due to pain & emotional distress and subsequent receipt of prescription medications among older adults with cancer.

Authors:  Carolyn J Presley; Maureen Canavan; Shi-Yi Wang; Shelli L Feder; Jennifer Kapo; Maureen L Saphire; Ella Sheinfeld; Erin E Kent; Amy J Davidoff
Journal:  J Geriatr Oncol       Date:  2020-03-10       Impact factor: 3.599

4.  Randomized controlled trial of collaborative care management of depression among low-income patients with cancer.

Authors:  Kathleen Ell; Bin Xie; Brenda Quon; David I Quinn; Megan Dwight-Johnson; Pey-Jiuan Lee
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

5.  Is screening effective in detecting untreated psychiatric disorders among newly diagnosed breast cancer patients?

Authors:  Steven C Palmer; Alison Taggi; Angela Demichele; James C Coyne
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

6.  Implementing a regional oncology information system: approach and lessons learned.

Authors:  W K Evans; F D Ashbury; G L Hogue; A Smith; J Pun
Journal:  Curr Oncol       Date:  2014-10       Impact factor: 3.677

7.  Relationship between anti-depressant use and lung cancer survival.

Authors:  Adriana Zingone; Derek Brown; Elise D Bowman; Oscar Vidal; Julien Sage; Joel Neal; Bríd M Ryan
Journal:  Cancer Treat Res Commun       Date:  2017-01-29

8.  Sertraline effectiveness and safety in depressed oncological patients.

Authors:  Riccardo Torta; Ilaria Siri; Paola Caldera
Journal:  Support Care Cancer       Date:  2007-09-14       Impact factor: 3.603

9.  Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors.

Authors:  Michael J Fisch; Fengmin Zhao; Judith Manola; Andrew H Miller; William F Pirl; Lynne I Wagner
Journal:  Psychooncology       Date:  2014-06-14       Impact factor: 3.894

10.  Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study.

Authors:  Kathleen Ell; Brenda Quon; David I Quinn; Megan Dwight-Johnson; Anjanette Wells; Pey-Jiuan Lee; Bin Xie
Journal:  Gen Hosp Psychiatry       Date:  2007 May-Jun       Impact factor: 3.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.